The serum estradiol concentration is the main determinant of the estradiol concentration in normal breast tissue

Maturitas

Volumn 81, Issue 1, 2015, Pages 42-45

  Depypere, H T ^a   Bolca, S ^b   Bracke, M ^a   Delanghe, J ^a   Comhaire, F ^a   Blondeel, Ph ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Aromatase inhibitor; Breast epithelium; Estradiol concentration; Tamoxifen

Indexed keywords

AROMATASE INHIBITOR; ESTRADIOL; ORAL CONTRACEPTIVE AGENT; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADULT; ARTICLE; BODY MASS; BREAST; BREAST BIOPSY; BREAST CANCER; BREAST REDUCTION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; ESTHETIC SURGERY; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; HUMAN TISSUE; MEDICAL HISTORY; MENSTRUAL CYCLE; PLASTIC SURGERY; POSTMENOPAUSE; PREMENOPAUSE; ADOLESCENT; BLOOD; BREAST NEOPLASMS; CHEMISTRY; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; BREAST; BREAST NEOPLASMS; CONTRACEPTIVES, ORAL; ESTRADIOL; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; TAMOXIFEN; YOUNG ADULT;

EID: 84928055463     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2015.01.014     Document Type: Article

References (27)

1. M.J. Mourits, E.G. de Vries, and P.H. Wilemse Ovarian cysts in women receiving tamoxifen for breast cancer Br J Cancer 79 1999 1761 1764
2. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), C. Davies, and J. Godwin Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials Lancet 378 August (9793) 2011 771 784
3. B. Fisher, J.P. Costantino, and D.L. Wickerham Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study J Natl Cancer Inst 97 2005 1652 1662
4. U. Veronesi, P. Maisonneuve, and N. Rotmensz Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention trial among women with hysterectomy J Clin Oncol 29 17 2011 2327 2333
5. T.J. Powles, S. Ashley, A. Tidy, I.E. Smith, and M. Dowsett Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial J Natl Cancer Inst 99 4 2007 283 290
6. J. Cuzick, J. Forbes, and R. Edwards First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial Lancet 14 360(9336) 2002 817 824
7. LHRH-Agonists in Early Breast Cancer Overview group, J. Cuzick, and L. Ambroisine Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomized adjuvant trials Lancet 19 369(9574) 2007 1711 1723
8. A.J. Tevaarwerk, M. Wang, and F. Zhao Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group J Clin Oncol 32 2014 1 15
9. S.M. Swain, J. Jeong, and C.E. Geyer Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer N Engl J Med 362 2010 2053 2065
10. P.A. Francis, M.M. Regan, and G.F. Fleming Adjuvant ovarian suppression in premenopausal breast cancer N Engl J Med December 2014 10.1056/NEJMoa1412379
11. I. Oren, S.J. Fleishman, A. Kessel, and N. Ben-Tal Free diffusion of steroid hormones across biomembranes: a simple search with implicit solvent model calculations Biophys J 87 2 2004 768 779
12. J.R. Pasqualini, J. Cortes-Prieto, G. Chetrite, M. Talbi, and A. Ruiz Concentrations of estrone, estradiol and their sulfates, and evaluation of sulfatase and aromatase activiteis in patients with breast fibroadenoma Int J Cancer 70 1997 639 643
13. A. Vermeulen, J.P. Deslypere, R. Paridaens, G. Leclercq, F. Roy, and J.C. Heuson Aromatase, 17 beta-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women Eur J Cancer Clin Oncol 22 1986 515 525
14. J.H. Thijssen, A.A. van Landeghem, and J. Poortman Uptake and concentration of steroid hormones in mammary tissues Ann N Y Acad Sci 464 1986 106 116
15. A.A. Van Landeghem, J. Poortman, M. Nabuurs, and J.H. Thijssen Endogenous concentration of subcellular distribution of estrogens in normal and malignant human breast tissue Cancer Res 45 1985 2900 2906
16. P.N. Blondeel One hundred free DIEP flap breast reconstructions: a personal experience Br J Plast Surg Mar 52 2 1999 104 111
17. G.S. Chetrite, J. Cortes-Prieto, J.C. Philippe, F. Wright, and J.R. Pasqualini Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues J Steroid Biochem Mol Biol 72 January-February (1-2) 2000 23 27
18. S. Bolca, M. Urpi-Sarda, and P. Blondeel Disposition of soy isoflavones in normal human breast tissue Am J Clin Nutr 91 April (4) 2010 976 984
19. J.R. Pasqualini, and G.S. Chetrite Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer J Steroid Biochem Mol Biol 93 2005 221 236
20. J.R. Pasqualini, G. Chetrite, and C. Blacker Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients J Clin Endocrinol Metab 81 1996 1460 1464
21. J. Geisler Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators J Steroid Biochem Mol Biol 86 2003 245 253
22. W.R. Miller, J. Telford, and C.D. Love Effects of letrozole as primary medical therapy on in situ oestrogen synthesis and endogenous oestrogen levels within the breast Breast 7 1998 273 276
23. L. Holmberg, H. Anderson, and HABITS Steering and Data Monitoring Committees HABITS (hormonal replacement therapy after breast cancer - is it safe?), a randomised comparison: trial stopped Lancet 363 9407 2004 453 455
24. E. von Schoultz, L.E. Rutqvist, and Stockholm Breast Cancer Study Group Menopausal hormone therapy after breast cancer: the Stockholm randomized trial J Natl Cancer Inst 97 7 2005 533 535
25. M. Fahlén, T. Fornander, and H. Johansson Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial Eur J Cancer 49 1 2013 52 59
26. V.C. Jordan The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer Endocr Relat Cancer 22 1 2015 R1 R11
27. I.E. Obiorah, P. Fan, S. Sengupta, and V.C. Jordan Selective estrogen-induced apoptosis in breast cancer Steroids 90 2014 60 70 10.1016/j.steroids.2014.06.003